Delivery Order SPE2DB20D3101-SPE2DB25FRTW5
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $36,326.13 delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of issue on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a $39,912.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on September 12, 2025, with completion targeted for September 15, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of use (UDS) on April 10, 2025, with a ceiling value of $3,423.88. This firm fixed-price delivery order, with an ultimate completion date of April 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $6,317.21 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units under delivery order contract 4569293882. The award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed price, competitively awarded contract with no set-aside designation. Performance will be conducted at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Emverm 100 mg tablet chewables in unit dose packaging, with a ceiling value of $1,559.56. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by May 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $65,417.77 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable unit dose supplies. This firm fixed-price delivery order, issued on August 19, 2025, represents a non-competitive set-aside contract with an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,427.06 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units under a firm fixed price contract type. This non-set-aside award was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime contractor for the DLA and is a major pharmaceutical distributor specializing in medical supply chain support for federal...
- The Defense Logistics Agency awarded a delivery order valued at $19,065.20 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units. This non-competitive, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,232.22 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of supply on August 19, 2025. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a $21,691.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewables under unit dose strip packaging. This competitively awarded contract, with no set-aside designation, was executed on September 2, 2025, with an ultimate completion date of September 3, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued against...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRTW5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,131.18 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Emverm 100 mg tablet chewable units of use. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor agreement running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical supplier to the Defense Logistics Agency's Medical Supply Chain. The company maintains an extensive portfolio of federal contract awards covering a broad spectrum of pharmaceutical products, medical devices, and specialized healthcare commodities supporting military and veteran healthcare systems. This delivery order for Emverm exemplifies the company's capability to fulfill federal medical procurement requirements through open competition, consistent with its demonstrated track record of supplying diverse pharmaceutical products ranging from specialty medications to generic drugs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.1k | 8/28/25 |